These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27656684)

  • 1. Purification of the subcellular compartment in which exogenous antigens undergo endoplasmic reticulum-associated degradation from dendritic cells.
    Imai J; Otani M; Sakai T; Hatta S
    Heliyon; 2016 Sep; 2(9):e00151. PubMed ID: 27656684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells.
    Imai J; Hasegawa H; Maruya M; Koyasu S; Yahara I
    Int Immunol; 2005 Jan; 17(1):45-53. PubMed ID: 15546887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation.
    Imai J; Otani M; Sakai T; Hatta S
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28872140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Subcellular Compartments of Dendritic Cells Used for Cross-Presentation.
    Imai J; Otani M; Sakai T
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
    Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
    Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells.
    Giodini A; Rahner C; Cresswell P
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3324-9. PubMed ID: 19218463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Vaccination with Boosted Cross Presentation by ER-Targeted Antigen Delivery for Anti-Tumor Immunotherapy.
    Shi Y; Zhu C; Liu Y; Lu Y; Li X; Qin B; Luo Z; Luo L; Jiang M; Zhang J; Guan G; Zheng C; You J
    Adv Healthc Mater; 2021 Apr; 10(8):e2001934. PubMed ID: 33502831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
    Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
    Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
    Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
    Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways for antigen cross presentation.
    Guermonprez P; Amigorena S
    Springer Semin Immunopathol; 2005 Jan; 26(3):257-71. PubMed ID: 15592842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.
    Ménager J; Ebstein F; Oger R; Hulin P; Nedellec S; Duverger E; Lehmann A; Kloetzel PM; Jotereau F; Guilloux Y
    PLoS One; 2014; 9(2):e89897. PubMed ID: 24587108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of endoplasmic reticulum stress in the MHC class I antigen presentation pathway of dendritic cells.
    Manoury B; Maisonneuve L; Podsypanina K
    Mol Immunol; 2022 Apr; 144():44-48. PubMed ID: 35184022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
    Svensson M; Wick MJ
    Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.